Drugs Made Financials
| DMAA Stock | 10.42 0.02 0.19% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Return On Equity | 1.57 | 1.77 |
|
| |||||
| Current Ratio | 5.02 | 5.65 |
|
|
Understanding current and past Drugs Made Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Drugs Made's financial statements are interrelated, with each one affecting the others. For example, an increase in Drugs Made's assets may result in an increase in income on the income statement.
Please note, the presentation of Drugs Made's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Drugs Made's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Drugs Made's management manipulating its earnings.
Drugs Made Stock Summary
Drugs Made competes with SIM Acquisition, Mountain Lake, Berto Acquisition, Centurion Acquisition, and Berto Acquisition. Drugs Made is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Financial Services, Financial Services |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | KYG2847J1040 |
| Business Address | 1 East Broward |
| Sector | Capital Markets |
| Industry | Financials |
| Benchmark | Dow Jones Industrial |
| Website | dmaacorp.com |
| Phone | 954 870 3099 |
Drugs Made Key Financial Ratios
| Book Value Per Share | (0.22) X | |||
| Market Capitalization | 349.92 M |
Drugs Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Drugs Made's current stock value. Our valuation model uses many indicators to compare Drugs Made value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Drugs Made competition to find correlations between indicators driving Drugs Made's intrinsic value. More Info.Drugs Made In is rated # 4 in current valuation category among its peers. It is rated # 2 in shares outstanding category among its peers creating about 0.10 of Shares Outstanding per Current Valuation. The ratio of Current Valuation to Shares Outstanding for Drugs Made In is roughly 10.44 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Drugs Made's earnings, one of the primary drivers of an investment's value.About Drugs Made Financials
What exactly are Drugs Made Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Drugs Made's income statement, its balance sheet, and the statement of cash flows. Potential Drugs Made investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Drugs Made investors may use each financial statement separately, they are all related. The changes in Drugs Made's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Drugs Made's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Drugs Made February 3, 2026 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Drugs Made help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Drugs Made In. We use our internally-developed statistical techniques to arrive at the intrinsic value of Drugs Made In based on widely used predictive technical indicators. In general, we focus on analyzing Drugs Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Drugs Made's daily price indicators and compare them against related drivers.
| Downside Deviation | 0.1599 | |||
| Information Ratio | (0.33) | |||
| Maximum Drawdown | 0.5781 | |||
| Value At Risk | (0.19) | |||
| Potential Upside | 0.194 |
Complementary Tools for Drugs Stock analysis
When running Drugs Made's price analysis, check to measure Drugs Made's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Drugs Made is operating at the current time. Most of Drugs Made's value examination focuses on studying past and present price action to predict the probability of Drugs Made's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Drugs Made's price. Additionally, you may evaluate how the addition of Drugs Made to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |